Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established During Clinical Trial 38826 for the Development of Org 36286 (Corifollitropin Alfa)
Phase of Trial: Phase II
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Corifollitropin alfa; Recombinant follicle-stimulating hormone
- Indications Infertility
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme; Organon
- 07 Oct 2009 Schering-Plough added as trial sponsor, affiliate and lead trial center as reported by ClinicalTrials.gov.
- 16 Jul 2008 New trial record.